A086450 Stock Overview
DongKook Pharmaceutical Co., Ltd. manufactures, sells, and imports of pharmaceuticals, quasi-drugs, and injections in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
DongKook Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩15,730.00 |
52 Week High | ₩19,620.00 |
52 Week Low | ₩13,000.00 |
Beta | 0.66 |
1 Month Change | -1.87% |
3 Month Change | -10.06% |
1 Year Change | 2.88% |
3 Year Change | -45.85% |
5 Year Change | 36.31% |
Change since IPO | 217.53% |
Recent News & Updates
Recent updates
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 06How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?
Mar 15The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?
Feb 28DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 14DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 19The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio
Jan 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting
Dec 21What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?
Dec 08The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It
Nov 23Shareholder Returns
A086450 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -3.0% | -5.0% | -4.3% |
1Y | 2.9% | -1.4% | -1.0% |
Return vs Industry: A086450 exceeded the KR Pharmaceuticals industry which returned -1.4% over the past year.
Return vs Market: A086450 exceeded the KR Market which returned -1% over the past year.
Price Volatility
A086450 volatility | |
---|---|
A086450 Average Weekly Movement | 4.6% |
Pharmaceuticals Industry Average Movement | 4.6% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A086450 has not had significant price volatility in the past 3 months.
Volatility Over Time: A086450's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1968 | 1,105 | Heung-Ju Oh | www.dkpharm.co.kr |
DongKook Pharmaceutical Co., Ltd. manufactures, sells, and imports of pharmaceuticals, quasi-drugs, and injections in South Korea and internationally. The company offers contrast media and medical devices. It also involved in real estate development business.
DongKook Pharmaceutical Co., Ltd. Fundamentals Summary
A086450 fundamental statistics | |
---|---|
Market cap | ₩691.53b |
Earnings (TTM) | ₩47.18b |
Revenue (TTM) | ₩730.99b |
14.7x
P/E Ratio0.9x
P/S RatioIs A086450 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A086450 income statement (TTM) | |
---|---|
Revenue | ₩730.99b |
Cost of Revenue | ₩320.44b |
Gross Profit | ₩410.55b |
Other Expenses | ₩363.38b |
Earnings | ₩47.18b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.07k |
Gross Margin | 56.16% |
Net Profit Margin | 6.45% |
Debt/Equity Ratio | 12.0% |
How did A086450 perform over the long term?
See historical performance and comparison